Performance characteristics of the Food and Drug Administration-licensed Roche Cobas TaqScreen West Nile virus assay.


BACKGROUND The cobas TaqScreen West Nile virus (WNV) test (Roche Molecular Systems) was licensed by the Food and Drug Administration (FDA) in August 2007 for detecting WNV RNA in pools of six or in individual donations (IDs). A series of studies established the performance characteristics of the assay and test system before FDA licensure. STUDY DESIGN AND… (More)
DOI: 10.1111/j.1537-2995.2008.01861.x

5 Figures and Tables


  • Presentations referencing similar topics